There is a clear correlation between higher expression of LAG3 in TIL and closer proximity of T cells to tumor cells, where LAG3 predicts more CD4 + or CD8 + T cells clustered around the tumor, and immune activation within the TME prompts more effector T cells to exert tumor-killing effects. Here, LAG3 is linked to neoplasm.